Yıl: 2020 Cilt: 27 Sayı: 1 Sayfa Aralığı: 97 - 104 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2019.11.779 İndeks Tarihi: 12-10-2020

Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey

Öz:
Aim: Breast cancer-related lymphedema (BCRL) is a disabling complication that can develop following breast cancer surgery monthsor even years after treatment ends. The effective management of BCRL requires adhering to simple risk-reduction strategies. Thestudy aim was to assess the awareness and knowledge of lymphedema risk-management behaviors among breast cancer survivorsand identify factors that affect it.Material and Methods: This study was conducted on 250 survivors of breast cancer. Demographic information, treatment details,time since surgery, duration and stage of lymphedema were recorded. Lymphedema education, knowledge about risk-minimizationrecommendations, and information sources were questioned using a survey. A multiple linear regression was used to identifypredictors of lymphedema awareness.Results: Just over half (53.6%) of the patients had adequate lymphedema awareness (score≥8). BCRL was detected in 121 (48.4%)patients. Awareness scores varied by age, education level, body mass index, receiving chemotherapy and radiotherapy, and a previousBCRL treatment (all p<0.05). Citing physiatrists as an information source reflected higher levels of awareness. Educational level andaxillary lymph node dissection were positive predictors; time since surgery was the only negative predictor of lymphedema awareness.Conclusion: This study highlights the lack of lymphedema awareness among survivors of breast cancer. Accurate, timely,individualized training programs can improve knowledge and compliance of lymphedema risk management behaviors.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ozmen V. Breast cancer in the world and Turkey. J Breast Health 2008;4:2-5.
  • 2. Stewart BW, Wild C. International Agency for Research on Cancer. World Health Organization. In: World Cancer Report 2014. Geneva: World Health Organization; 2014.
  • 3. Hayes SC, Janda M, Cornish B, et al. Lymphedema after breast cancer: Incidence, risk factors, and effect on upper body function. J Clin Oncol 2008;26;3536- 42.
  • 4. Agrawal S. Late effects of cancer treatment in breast cancer survivors. South Asian J Cancer 2014;3:112-5.
  • 5. Borman P. Lymphedema diagnosis, treatment, and follow-up from the view point of physical medicine and rehabilitation specialists. Turk J Phys Med Rehab 2018;64:179-97.
  • 6. Bakar Y, Berdici B, Sahin N, et al. Lymphedema after breast cancer and its treatment. Eur J Breast Health 2014;10:6-14.
  • 7. Disipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol 2013;14:500-15.
  • 8. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
  • 9. Keast DH, Despatis M, Allen JO, et al. Chronic oedema/ lymphedema:under-recognized and under-treated. Int Wound J 2015;12:328-33.
  • 10. Lee YM, Mak SS, Tse SM, et al. Lymphoedema care of breast cancer patients in a breast care clinic: a survey of knowledge and health practice. Support Care Cancer 2001;9:634-41.
  • 11. Ganz PA, Yip CH, Gralow JR, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low-middle in-come countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013;22:606-15.
  • 12. Bani HA, Fasching PA, Lux MM, et al. Lymphedema in breast cancer survivors: As-sessment and information provision in a specialized breast unit. Patient Educ Couns 2007;66:311-8.
  • 13. Bosompra K, Ashikaga T, O’Brien PJ, et al. Knowledge about preventing and managing lymphedema: a survey of recently diagnosed and treated breast cancer patients. Patient Educ Couns 2002;47:155- 163.
  • 14. Sherman KA, Koelmeyer L. The role of information sources and objective risk status on lymphedema riskminimization behaviors in women recently diagnosed with breast cancer. Oncol Nurs Forum 2011;38:27-36.
  • 15. Choi JK, Kim HD, Sim YJ, et al. A Survey of the Status of Awareness of Lymphedema in Breast Cancer Patients in Busan-Gyeongnam, Korea. Ann Rehabil Med 2015;39:609-15.
  • 16. Borman P, Yaman A, Yasrebi S, et al. The Importance of Awareness and Education in Patients with Breast Cancer-Related Lymphedema. J Cancer Educ 2017;32:629-33.
  • 17. Bilodeau BA, Degner LF. Information needs, sources of information, and decisional roles in women with breast cancer. Oncol Nurs Forum 1996;23:691-6.
  • 18. Çal A, Bahar Z. Women’s barriers to prevention of lymphedema after breast surgery and home care needs: a qualitative study. Cancer Nurs 2016;39:17-25.
  • 19. Deng J, Fu MR, Armer JM, et al. Factors associated with reported infection and lymphedema symptoms among individuals with extremity lymphedema. Rehabil Nurs 2015;40:310-9.
  • 20. Kwan ML, Shen L, Munneke JR, et al. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat 2012;135:591-602.
  • 21. Fu MR, Chen CM, Haber J, et al. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Ann Surg Oncol 2010;17:1847-53.
  • 22. Herberger K, Blome C, Sandner A, et al. Quality of care of patients with chronic lymphoedema in Germany. Dermatology 2013;226:238-46.
  • 23. Coward, D.D. Lymphedema prevention and management knowledge in women treated for breast cancer. Oncol Nurs Forum 1999;26:1047-53.
  • 24. Morcos BB, Al Ahmad F, Anabtawi I, et al. Lymphedema. A significant health problem for women with breast cancer in Jordan. Saudi Med J 2013;34:62-6.
  • 25. Tam EK, Shen L, Munneke JR, et al. Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Res Treat 2012;131:1029-38.
  • 26. Executive Committee. The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology. Lymphology. 2016;49:170-84.
  • 27. Lenfödemli hastalar için genel bilgi ve uyarılar. Avaliable at: http://www.lenfodemdernegi.org.tr Access date:11.09.2019
  • 28. Jammallo LS, Miller CL, Singer M, et al. Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat 2013;142:59-67.
  • 29. Zou L, Liu FH, Shen PP, et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer 2018;25:309- 14.
  • 30. Ridner SH, Dietrich MS, Stewart BR, et al. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011;19:853-7.
APA Tolu S, Basim P (2020). Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. , 97 - 104. 10.5455/annalsmedres.2019.11.779
Chicago Tolu Sena,Basim Pelin Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. (2020): 97 - 104. 10.5455/annalsmedres.2019.11.779
MLA Tolu Sena,Basim Pelin Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. , 2020, ss.97 - 104. 10.5455/annalsmedres.2019.11.779
AMA Tolu S,Basim P Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. . 2020; 97 - 104. 10.5455/annalsmedres.2019.11.779
Vancouver Tolu S,Basim P Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. . 2020; 97 - 104. 10.5455/annalsmedres.2019.11.779
IEEE Tolu S,Basim P "Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey." , ss.97 - 104, 2020. 10.5455/annalsmedres.2019.11.779
ISNAD Tolu, Sena - Basim, Pelin. "Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey". (2020), 97-104. https://doi.org/10.5455/annalsmedres.2019.11.779
APA Tolu S, Basim P (2020). Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. Annals of Medical Research, 27(1), 97 - 104. 10.5455/annalsmedres.2019.11.779
Chicago Tolu Sena,Basim Pelin Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. Annals of Medical Research 27, no.1 (2020): 97 - 104. 10.5455/annalsmedres.2019.11.779
MLA Tolu Sena,Basim Pelin Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. Annals of Medical Research, vol.27, no.1, 2020, ss.97 - 104. 10.5455/annalsmedres.2019.11.779
AMA Tolu S,Basim P Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. Annals of Medical Research. 2020; 27(1): 97 - 104. 10.5455/annalsmedres.2019.11.779
Vancouver Tolu S,Basim P Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey. Annals of Medical Research. 2020; 27(1): 97 - 104. 10.5455/annalsmedres.2019.11.779
IEEE Tolu S,Basim P "Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey." Annals of Medical Research, 27, ss.97 - 104, 2020. 10.5455/annalsmedres.2019.11.779
ISNAD Tolu, Sena - Basim, Pelin. "Awareness of lymphedema risk management behaviors and associated factors among breast cancer survivors: Results from a cross-sectional survey". Annals of Medical Research 27/1 (2020), 97-104. https://doi.org/10.5455/annalsmedres.2019.11.779